Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 3
254
Views
28
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Pharmacokinetics and brain penetration study of chlorogenic acid in rats

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 339-345 | Received 07 Jan 2018, Accepted 23 Feb 2018, Published online: 21 Mar 2018

References

  • Ahn EH, Kim DW, Shin MJ, et al. (2011). Chlorogenic acid improves neuroprotective effect of PEP-1-ribosomal protein S3 against ischemic insult. Exp Neurobiol 20:169–75.
  • Azuma K, Ippoushi K, Nakayama M, et al. (2000). Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J Agric Food Chem 48:5496–500.
  • Chauhan MB, Chauhan NB. (2015). Brain uptake of neurotherapeutics after intranasal versus intraperitoneal delivery in mice. J Neurol Neurosurg 2.
  • Clifford MN. (1999). Chlorogenic acids and other cinnamates–nature, occurrence and dietary burden. J Sci Food Agric 79:362–72.
  • Clifford MN, Jaganath IB, Ludwig IA, Crozier A. (2017). Chlorogenic acids and the acyl-quinic acids: discovery, biosynthesis, bioavailability and bioactivity. Nat Prod Rep 34:1391–421.
  • Clifford MN. (2000). Chlorogenic acids and other cinnamates–nature, occurrence, dietary burden, absorption and metabolism. J Sci Food Agric 80:1033–43.
  • Dhuria SV, Hanson LR, Frey WH. (2010). Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654–73.
  • Farah A, Monteiro M, Donangelo CM, Lafay S. (2008). Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 138:2309–15.
  • Gao R, Lin Y, Liang G, et al. (2014). Comparative pharmacokinetic study of chlorogenic acid after oral administration of Lonicerae Japonicae Flos and Shuang‐Huang‐Lian in normal and febrile rats. Phytother Res 28:144–7.
  • Gebara KS, Gasparotto-Junior A, Santiago PG, et al. (2017). Daily intake of chlorogenic acids from consumption of mate (Ilex paraguariensis A. St.-Hil.) traditional beverages. J Agric Food Chem 65:10093–100.
  • George SE, Ramalakshmi K, Mohan Rao LJ. (2008). A perception on health benefits of coffee. Crit Rev Food Sci Nutr 48:464–86.
  • Graff CL, Pollack GM. (2005). Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 94:1187–95.
  • Grassin-Delyle S, Buenestado A, Naline E, et al. (2012). Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther 134:366–79.
  • Guo Z, Li J. (2017). Chlorogenic acid prevents alcohol-induced brain damage in neonatal rat. Transl Neurosci 8:176–81.
  • Hanson LR, Frey WH. (2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9:S5.
  • Higdon JV, Frei B. (2006). Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101–23.
  • Huang SM, Chuang HC, Wu CH, Yen GC. (2008). Cytoprotective effects of phenolic acids on methylglyoxal‐induced apoptosis in Neuro‐2A cells. Mol Nutr Food Res 52:940–9.
  • Illum L. (2000). Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1–18.
  • Ito H, Sun XL, Watanabe M, et al. (2008). Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci Biotechnol Biochem 72:885–8.
  • Jung JW, Kim JM, Jeong JS, et al. (2014). Pharmacokinetics of chlorogenic acid and corydaline in DA-9701, a new botanical gastroprokinetic agent, in rats. Xenobiotica 44:635–43.
  • Kaur P, Kim K. (2008). Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits. Int J Pharm 364:27–35.
  • Kumar G, Paliwal P, Patnaik R. (2017a). Withania somnifera phytochemicals confer neuroprotection by inhibition of the catalytic domain of human matrix metalloproteinase-9. Lett Drug Des Discov 14:718–26.
  • Kumar G, Paliwal P, Patnaik N, Patnaik R. (2017b). Withania somnifera phytochemicals confer neuroprotection by selective inhibition of nNos: an in silico study to search potent and selective inhibitors for human nNOS. J Theor Comput Chem 16:1750042.
  • Kumar G, Patnaik R. (2016). Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: an in silico study. Med Hypotheses 92:35–43.
  • Kumar G, Patnaik R. (2017). Inhibition of gelatinases (MMP-2 and MMP-9) by Withania somnifera phytochemicals confers neuroprotection in stroke: an in silico analysis. Interdiscip Sci Comput Life Sci. [Epub ahead of print]. DOI:10.1007/s12539-017-0231-x
  • Lardeau A, Poquet L. (2013). Phenolic acid metabolites derived from coffee consumption are unlikely to cross the blood–brain barrier. J Pharm Biomed Anal 76:134–8.
  • Lee K, Lee JS, Jang HJ, et al. (2012). Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in a rat model of focal cerebral ischemia. Eur J Pharmacol 689:89–95.
  • Manjunath MJ. (2015). Standardized extract of Withania somnifera (Ashwagandha) markedly offsets rotenone-induced locomotor deficits, oxidative impairments and neurotoxicity in Drosophila melanogaster. J Food Sci Technol 52:1971–81.
  • Meng D, Lu H, Huang S, et al. (2014). Comparative pharmacokinetics of tetramethylpyrazine phosphate in rat plasma and extracellular fluid of brain after intranasal, intragastric and intravenous administration. Acta Pharm Sin B 4:74–8.
  • Miao M, Cao L, Li R, et al. (2017). Protective effect of chlorogenic acid on the focal cerebral ischemia reperfusion rat models. Saudi Pharm J 25:556–63.
  • Muddana NR, Benade V, Paliwal P, et al. (2014). Neuro-pharmacokinetics based prediction of p-glycoprotein liability in early drug discovery. Drug Metab Rev 45:111–2.
  • Nirogi R, Kandikere V, Mudigonda K, et al. (2009). A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system. J Neurosci Methods 178:116–19.
  • Olthof MR, Hollman PC, Katan MB. (2001). Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131:66–71.
  • Paliwal P, Dash D, Krishnamurthy S. (2017). Pharmacokinetic study of piracetam in focal cerebral ischemic rats. Eur J Drug Metab Pharmacokinet. [Epub ahead of print]. DOI:10.1007/s13318-017-0435-9
  • Shen W, Qi R, Zhang J, et al. (2012). Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons. Brain Res Bull 88:487–94.
  • Shrivastava A, Gupta V. (2011). Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron Young Sci 2:21–5.
  • Taram F, Winter AN, Linseman DA. (2016). Neuroprotection comparison of chlorogenic acid and its metabolites against mechanistically distinct cell death-inducing agents in cultured cerebellar granule neurons. Brain Res 1648:69–80.
  • Yang H, Yuan B, Li L, et al. (2004). HPLC determination and pharmacokinetics of chlorogenic acid in rabbit plasma after an oral dose of Flos Lonicerae extract. J Chromatogr Sci 42:173–6.
  • Yuan B, Qiao M, Xu H, et al. (2006). Determination of chlorogenic acid in rat plasma by high performance chromatography after peritoneal administration of compound Daqingye injection. Yakugaku Zasshi 126:811–14.
  • Zhang Y, Huo M, Zhou J, Xie S. (2010). PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 99:306–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.